Progress in cancer diagnostics: Scientists of Jacobs University Bremen launched a company for biomedical reagents
T cells are white blood cells of the immune system that have amazing properties: they can detect cancer cells and virus-infected cells in the body, and they can often even attack and eliminate such disease agents. This is why T cells are an important part of the immune response that a patient makes against tumors and viruses. Researchers from Jacobs University Bremen, led by Prof. Sebastian Springer, and from the Technical University of Denmark have now co-founded a company to sell reagents that help doctors and scientists track down T cells and determine what disease factors they can attack.
